Soaring debt needs tighter credit checks
Tomorrow, the Government will announce the biggest shake-up in the regulation of credit in 30 years. Timed to coincide with the Christmas spending binge, it will aim to t...
|
|
We don't like expensive fixes
Borrowers who lock into a fixed rate now - in the hope of beating future rate rises -will effectively be locking into a deal that has already factored in these rises.
T...
|
|
Queen's speech: child trust funds
The Queen announced the introduction of a bill that will "provide all children born from September 2002 with a child trust fund with an initial endowment from the governm...
|
|
Queen's speech: key personal finance issues
Pensions bill
The Queen announced legislation aimed at encouraging employers to provide good quality pensions and individuals to save more effectively for their retirem...
|
|
New CSA computer system fails to deliver
Tens of thousands of single parents are facing chronic delays in support payments because of the latest problems to hit a new government computer system.
Official figure...
|
|
Dabbling in the Black arts
The Company is indebted to RMI as a consequence of the sale of NP Holdings Company and its related tax losses to RMI on July 3, 2002. Prior to the sale, NP Holdings had n...
|
|
PFI schemes 'at odds' with NHS changes
Private finance deals for hospitals are under strain because they are too inflexible to incorporate changes to government health policy, NHS managers warned today.
Sylvi...
|
|
Fraud virus attacks PayPal
Users of the internet payment service PayPal were today warned about a new virus that tries to trick them into revealing their bank details and other personal information...
|
|
Hollinger credit rating at risk
Lord Black's control of Hollinger International, the company which owns the Telegraph titles, is under immediate threat after the severing of a financial lifeline feeding...
|
|
CAT sues partner for bigger share of first drug royalties
Cambridge Antibody Technology is suing its partner Abbott Laboratories in the high court over its share of royalty payments for its first drug on the market, the rheumato...
|
|